Ignite Creation Date:
2024-05-06 @ 10:40 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03329950
Status:
COMPLETED
Last Update Posted:
2024-03-28
First Post:
2017-10-23
Brief Title:
A Study of CDX-1140 CD40 as Monotherapy or in Combination in Patients With Advanced Malignancies
Sponsor:
Celldex Therapeutics
Organization:
Celldex Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Follicular Lymphoma |
| Melanoma |
| Non-small Cell Lung Cancer |
| Breast Cancer |
| Gastric Cancer |
| Renal Cell Carcinoma |
| Ovarian Cancer |
| Cholangiocarcinoma |
| Bladder Urothelial Carcinoma |
| Pancreatic Adenocarcinoma |
| Colorectal Cancer |
| Esophageal Cancer |
| Hepatic Cancer |
| Head and Neck Cancer |
| Primary Peritoneal Cancer |
| Fallopian Tube Cancer |
| Other Solid Tumors |
| Diffuse Large B-cell Lymphoma DLBCL |
| Mantle Cell Lymphoma |
| Indolent B-cell Lymphomas |
| Non-Hodgkin Lymphoma |
| Lymphoplasmacytic Lymphoma |
| Waldenstroms Disease |
| Marginal Zone Lymphoma |
| Mucosa Associated Lymphoid Tissue |
| Small Lymphocytic Leukemia |
Keywords:
| Name | View |
|---|---|
| CDX-1140 | View |
| Solid Tumors | View |
| Liver Cancer | View |
| GI Cancer | View |
| Kidney Cancer | View |
| Celldex | View |
| Monoclonal | View |
| Antibody | View |
| CD40 | View |
| CD-40 | View |
| Flt3l | View |
| CDX-301 | View |
| Lung Cancer | View |
| Bile duct cancer | View |
| TNBC | View |
| RCC | View |
| Non-Hodgkin Lymphoma | View |
| Follicular Lymphoma | View |
| Dendritic cell | View |
| Keynote A-23 | View |
| pembrolizumab | View |
| Keytruda | View |
| Chemotherapy | View |
| Gemcitabine | View |
| Nab-paclitaxel | View |
| CD40L | View |
| CD40 Ligand | View |
| Pancreas cancer | View |
| Metastatic pancreas cancer | View |
| Unresectable pancreas cancer | View |
| Stage IV pancreas cancer | View |
| Squamous cell cancer lung | View |
| Non-squamous cell cancer lung | View |
| Metastatic lung cancer | View |
| Stage IV lung cancer | View |
| Squamous cell cancer of head and neck | View |
| Stage IV cancer of head and neck | View |
| Throat cancer | View |
| Oropharyngeal cancer | View |
| Laryngeal cancer | View |
| Oral cancer | View |
| FLT3 Ligand | View |
| fms-like tyrosine kinase 3 ligand | View |
| KEYTRUDA | View |